| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |